XTalks

DECEMBER 13, 2023

This episode features an interview with vaccine scientists and executives from Vaccines Global Clinical Development at Merck, Dr. Heather Platt, MD, Distinguished Scientist and Pneumococcal Vaccine Lead; and Dr. Ulrike Buchwald, MD, Scientific Associate Vice President, Global Clinical Research and Pneumococcal Vaccine Section Head.

Life Science 52

Life Science Vaccination Vaccine Scientist 52

XTalks

NOVEMBER 8, 2023

In this episode, Ayesha talked about the FDA’s acceptance of AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Vaccination Vaccine Licensing 52

Pharmaceutical Technology

MAY 23, 2023

Croda Pharma has entered a strategic collaboration deal with Botanical Solution Inc (BSI) to expedite the production of sustainable pharmaceutical-grade vaccine adjuvant QS-21. The plentiful supply of QS-21 enables the production of next-generation adjuvant systems for new vaccine development.”

Production 240

Production Vaccination Vaccine Life Science 240

Drug Discovery World

MARCH 7, 2023

For International Women’s Day, DDW’s Diana Spencer celebrates some of the women in leadership making an impact on the drug discovery and life sciences sector. The life sciences sector has traditionally outperformed others when it comes to attracting women to its workforce. Dr Loubna Bouarfa, Founder and CEO, OKRA.ai

Life Science 98

Life Science DNA Clinical Development Development 98

XTalks

JULY 6, 2022

In this episode, Ayesha discussed a new collaboration between leading medical technology company Becton Dickinson (BD) and CerTest Biotec who will work together to develop a molecular diagnostic test for the detection of the monkeypox virus. Hear about the vaccine trials and parents’ attitudes towards vaccinating younger children.

Life Science 52

Life Science Vaccination Vaccine Development 52

XTalks

DECEMBER 20, 2023

In 2023, there were significant advancements and notable trends in the life sciences. These advancements and trends addressed important industry challenges and offered opportunities to foster innovations and solutions in areas including drug development, healthcare and medical devices. billion in 2022.

Life Science 59

Life Science Clinical Trials Clinical Trials FDA Approval 59

XTalks

MARCH 8, 2022

On International Women’s Day, Xtalks is celebrating women’s leadership in the life sciences by highlighting some of the female leaders at the forefront of scientific discovery, as well as the continuing challenges of attaining more equitable representation.

Life Science 105

Life Science Gene Therapy DNA Vaccination 105

BioSpace

JULY 12, 2022

In what seems like an unlikely collaboration, Seattle-based Fred Hutchinson Cancer Center (Fred Hutch) is partnering with Amazon to develop cancer vaccines.

Life Science 96

Life Science Vaccination Vaccine Development 96

XTalks

OCTOBER 4, 2023

Elmar Joura, Associate Professor of Gynecology in the Department of Obstetrics and Gynecology at the Medical University of Vienna, who spoke to Xtalks about exciting new long-term Gardasil vaccine data from a study he led as principal investigator that showed the long-term impact of HPV vaccination.

Life Science 52

Life Science Vaccination Vaccine Antibody 52

BioSpace

MARCH 26, 2024

Moderna has entered into a development and commercialization funding agreement with asset management firm Blackstone Life Sciences to help advance its pipeline of flu vaccine candidates.

Life Science 129

Life Science Vaccination Vaccine Development 129

XTalks

MAY 10, 2023

In this episode, Ayesha talked about the FDA approval of the world’s first vaccine for respiratory syncytial virus (RSV). The vaccine is approved for adults 60 years of age and older. Read more about the vaccine, including clinical trial results on its efficacy and safety.

Life Science 52

Life Science Vaccination Vaccine FDA Approval 52

XTalks

FEBRUARY 19, 2024

Moderna has been testing an experimental mRNA vaccine aimed at combating the human cytomegalovirus (CMV), which poses significant health risks to newborns and immunocompromised patients. The team used the data and patient samples from a gB/MF59 Phase II trial in adolescent girls as a benchmark to assess the new mRNA-based vaccine.

Vaccination 59

Vaccination Vaccine Trials Clinical Trials 59

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year continued to be dominated by COVID-19, and the second year of the pandemic was all about vaccines. COVID-19: The Pandemic and the Vaccines.

Life Science 98

Life Science Vaccination Vaccine Trials 98

Scienmag

FEBRUARY 24, 2022

To address climbing economic losses from swine that contract the porcine epidemic diarrhea virus, Virginia Tech researchers in the College of Agriculture and Life Sciences and Virginia-Maryland College of Veterinary Medicine are developing a vaccine to combat the disease that has a near 100 percent mortality rate in newborn piglets.

Vaccination 77

Vaccination Vaccine Development Research 77

pharmaphorum

MARCH 12, 2021

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. And those volumes will only increase. From face-to-face to FaceTime.

Life Science 111

Life Science Regulation Genome Genomics 111

XTalks

NOVEMBER 23, 2022

Tzield is an immunotherapy that was in development for over three decades. Ayesha also talked about the latest positive Phase III trial data that Pfizer recently shared for its maternal RSV vaccine candidate. Pfizer Shares Positive Phase III Data for Maternal RSV Vaccine Candidate.

Life Science 52

Life Science FDA Approval Vaccination Vaccine 52

XTalks

OCTOBER 13, 2021

In addition to timely diagnosis, there may soon be a preventative vaccine for inflammatory arthritic conditions such as rheumatoid arthritis. Researchers at the University of Toledo have developed a vaccine against inflammatory arthritis that has shown promise in animal models.

Insulin 59

Insulin Life Science Vaccination Vaccine 59

XTalks

APRIL 28, 2021

Stories about the development of COVID-19 vaccines have dominated the news for months, but a huge breakthrough in the prevention of another infectious disease has just been announced. Read the full articles here: Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy. How Sugar May Impair Brain Development in Children.

Life Science 52

Life Science Vaccination Vaccine Development 52

pharmaphorum

MARCH 4, 2021

UK chancellor Rishi Sunak has announced a budget loaded with initiatives designed to kick-start the UK’s economy as it recovers from the coronavirus pandemic, with vaccine development, pharma and life sciences playing a key role.

Vaccination 105

Vaccination Vaccine Development Life Science 105

pharmaphorum

APRIL 4, 2022

Multinational insurance company AXA has launched a new €440 million ($500 million) drive to provide private equity investments in healthcare companies that deepens its interest in the life sciences sector. It is a major backer of Kadans, one of the groups behind the recently-announced Canary Wharf life sciences hub in east London.

Life Science 59

Life Science Vaccination Vaccine Marketing 59

XTalks

APRIL 20, 2022

In this episode, Ayesha discussed BioNTech’s new collaboration with Matinas BioPharma to explore the company’s lipid nanocrystal (LNC) delivery technology for mRNA vaccines. LNC structures are more stable than the lipid nanoparticle technology used in the current COVID-19 mRNA vaccines. in a $525 million deal.

Life Science 52

Life Science Vaccination Vaccine Development 52

XTalks

DECEMBER 29, 2022

The life sciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the life sciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.

Life Science 52

Life Science Gene Therapy Gene Manufacturing 52

XTalks

APRIL 21, 2021

More cases of blood clots in those vaccinated against COVID-19 — this time in six women who took the J&J shot — has US regulators recommending that vaccination efforts be paused. US Regulators Recommend Pause on J&J’s COVID-19 Vaccine, But Just as a Precaution.

Life Science 52

Life Science Vaccination Vaccine FDA Approval 52

XTalks

JULY 22, 2021

Soumya Swaminathan made comments in a press briefing about mixing and matching COVID-19 vaccines and how there is currently no data to support additional doses and boosters at this time. The test was developed by researchers at the University of Newcastle in Australia and involves a strip with a glucose biosensor.

Life Science 98

Life Science Vaccination Vaccine Scientist 98

pharmaphorum

DECEMBER 1, 2021

Bruntwood SciTech is the UK’s leading property provider dedicated to driving the growth of the science and technology sector. UK life sciences are buoyant with the success of the COVID-19 vaccine programme and a stream of innovation and investment marking it out for a starring role in the UK’s economic future.

Life Science 52

Life Science Vaccination Vaccine Development 52

XTalks

MARCH 26, 2021

In Episode 3 of the Xtalks Life Science Podcast, the team reflects on the 1-year anniversary of the start of the COVID-19 pandemic. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. The 4 Biggest Cancer Biotech Acquisitions of 2021 So Far.

Life Science 76

Life Science Vaccination Vaccine Development 76

Drug Discovery World

MAY 13, 2024

Reece Armstrong speaks to Melanie Adams-Cioaba , Senior Director and General Manager of pharma (cryo-EM), Thermo Fisher Scientific about advances in vaccine design. Using structural biology as central to vaccine design and development, and to drug discovery more generally, is what we mean by “rational design.”

Vaccination 59

Vaccination Vaccine Protein Antibody 59

pharmaphorum

JUNE 3, 2021

The arrival of G7 health ministers to Oxford this week (Thursday 3 June) will shine a spotlight on Oxfordshire’s considerable achievements in the life sciences sector – and, according to the county’s Local Enterprise Partnership, there couldn’t be a better location globally for this summit to be held.

Life Science 52

Life Science Vaccination Vaccine Development 52

XTalks

MAY 28, 2024

In a move signaling a major shift in influenza prevention strategies, CSL Seqirus, a global leader in flu vaccines, has transitioned from quadrivalent to trivalent formulations for the upcoming 2024/25 flu season in the US.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

BioPharma Reporter

SEPTEMBER 14, 2023

Vaxess Technologies, a life sciences company developing a shelf-stable vaccine patch with potential for self-application, has announced an additional $9 million in venture capital funding, with investors including RA Capital, The Engine, and GHIC, and Ulu Ventures.

Vaccination 64

Vaccination Vaccine Life Science Engineer 64

pharmaphorum

JULY 7, 2021

The UK’s long-awaited Life Sciences Vision strategy has been published, setting out the government’s stall as it tries to deliver on its promise to keep the country at the forefront of the sector. ” The post Dementia, cancer headline UK’s 10-year plan for life sciences sector appeared first on.

Life Science 59

Life Science Manufacturing Genome Genomics 59

STAT News

JANUARY 19, 2023

Journalist Nathan Vardi joins us to talk about his new book delving into the race to develop the lifesaving cancer drug now called Imbruvica, involving a Scientologist CEO and secretive investor seeking redemption after the worst trade of his life. Read the rest…

Vaccination 115

Vaccination Vaccine Life Science RNA 115

pharmaphorum

DECEMBER 22, 2022

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna. The first vaccines are due to be produced at the new facility in 2025.

Vaccination 122

Vaccination Vaccine Life Science Manufacturing 122

XTalks

APRIL 18, 2022

Top COVID-19 mRNA vaccine maker BioNTech is setting out to explore new and improved delivery technologies for mRNA vaccines, recently announcing a collaboration with New Jersey-based lipid nanocrystal developer Matinas BioPharma. The Pfizer-BioNTech COVID-19 vaccine Comirnaty must be stored at -90°C to -60°C.

Vaccination 105

Vaccination Vaccine Development Immune Response 105

XTalks

MAY 6, 2021

But rather than looking at these circumstances as barriers, job seekers should keep an open mind and rest assured that there are a wide range of jobs in the life sciences fields, like the pharmaceutical and medical device industries. Research and development (R&D). Formulation and development. Quality control.

Life Science 91

Life Science Manufacturing Engineer Vaccination 91

XTalks

DECEMBER 15, 2021

The team also talked about results from an early-stage trial evaluating Moderna’s new mRNA-based influenza vaccine in adults. The results showed that the vaccine had no serious safety concerns and elicits immune responses against four different strains of the influenza virus.

Life Science 52

Life Science FDA Approval Vaccination Vaccine 52

Drug Discovery World

OCTOBER 11, 2023

MinervaX, a Danish biotechnology company developing a novel, prophylactic vaccine against Group B streptococcus (GBS), has announced the completion of €54 million upsized financing. GBS is a leading cause of life-threatening infections in newborns as well as adverse pregnancy outcomes such as preterm delivery and stillbirths.

Vaccination 59

Vaccination Vaccine Clinical Trials Clinical Trials 59